Healthcare -
Biotechnology - NASDAQ - US
$ 10.7
0.375 %
$ 651 M
Market Cap
-3.19
P/E
Price Target
Average
263.15%
Revenue Forecast
Estimate
346.79%
EBIT
Estimate
14.97%
Net Income
Estimate
8.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pliant Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PLRX of $38.9 , with forecasts ranging from
a
low of
$32 to a high of $48 .
PLRX Lowest Price Target
Wall Street Target
32 USD
199.07%
PLRX Average Price Target
Wall Street Target
38.9 USD
263.15%
PLRX Highest Price Target
Wall Street Target
48 USD
348.60%
REVENUE FORECAST
Revenue Forecast Chart PLRX
EBIT FORECAST
EBIT Forecast Chart PLRX
NET INCOME FORECAST
Net Income Chart PLRX